Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract 1157: MicroRNA-625-3p is associated with response to first-line oxaliplatin-based treatment of metastatic colorectal cancer.

Mads H. Rasmussen, Niels F. Jensen, Line S. Tarpgaard, Camilla Qvortrup, Maria U. Rømer, Jan Stenvang, Tine P. Hansen, Lise-Lotte Christensen, Jan Lindebjerg, Flemming Hansen, Benny V. Jensen, Torben F. Hansen, Anders M. Jakobsen, Per Pfeiffer, Nils Brünner, Torben F. Ørntoft, Claus L. Andersen

Cancer Res (2013) 73 (8_Supplement): 1157.

https://doi.org/10.1158/1538-7445.AM2013-1157

Published: 15 April 2013

View article titled, Abstract 1157: MicroRNA-625-3p is associated with response to first-line oxaliplatin-based treatment of metastatic colorectal cancer.

Journal Articles

Abstract 1912: An explorative analysis of ERCC1/ERCC4 copy number alterations in a chemonaive stage III colorectal cancer patient cohort.

David H. Smith, Niels F. Jensen, Ib J. Christensen, Sven Müller, Hans J. Nielsen, Nils Brünner, Kirsten V. Nielsen

Cancer Res (2013) 73 (8_Supplement): 1912.

https://doi.org/10.1158/1538-7445.AM2013-1912

Published: 15 April 2013

View article titled, Abstract 1912: An explorative analysis of <em>ERCC1/ERCC4</em> copy number alterations in a chemonaive stage III colorectal cancer patient cohort.

Journal Articles

Abstract LB-476: A universal method for elimination of haemolyzed plasma samples that improves miRNA signature performance for early detection of colorectal cancer

Søren J. Nielsen, Thorarinn Blondal, Maria W. Teilum, Claus L. Andersen, Torben Orntoft, Nils Brünner, Jan Stenvang, Hans J. Nielsen, Adam Baker, Peter Mouritzen

Cancer Res (2012) 72 (8_Supplement): LB-476.

https://doi.org/10.1158/1538-7445.AM2012-LB-476

Published: 15 April 2012

View article titled, Abstract LB-476: A universal method for elimination of haemolyzed plasma samples that improves miRNA signature performance for early detection of colorectal cancer

Journal Articles

Abstract 5563: Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

Charlotte Aaberg-Jessen, Stine S. Jensen, Signe L. Nielsen, Christian B. Pedersen, Nils Brünner, Bjarne W. Kristensen

Cancer Res (2012) 72 (8_Supplement): 5563.

https://doi.org/10.1158/1538-7445.AM2012-5563

Published: 15 April 2012

View article titled, Abstract 5563: Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

Journal Articles

Abstract 2816: Discovery of a miRNA-based RT-qPCR signature able to detect early stage colorectal cancer in blood plasma

Søren J. Nielsen, Hanni Willenbrock, Jacob U. Fog, Nana Jacobsen, Jan Stenvang, Thorarinn Blondal, Torben Ørntoft, Nils Brünner, Claus L. Andersen, Hans J. Nielsen, Adam Baker

Cancer Res (2011) 71 (8_Supplement): 2816.

https://doi.org/10.1158/1538-7445.AM2011-2816

Published: 15 April 2011

View article titled, Abstract 2816: Discovery of a miRNA-based RT-qPCR signature able to detect early stage colorectal cancer in blood plasma

Journal Articles

Abstract 1214: TIMP-1 and the TIMP-1 interacting cell surface protein CD63 in cultured astrocytoma derived spheroids: expression and co-expression with stem cell markers

Charlotte Aaberg-Jessen, Henrik D. Schrøder, Claus Andersen, Nils Brünner, Bjarne W. Kristensen

Cancer Res (2010) 70 (8_Supplement): 1214.

https://doi.org/10.1158/1538-7445.AM10-1214

Published: 15 April 2010

View article titled, Abstract 1214: TIMP-1 and the TIMP-1 interacting cell surface protein CD63 in cultured astrocytoma derived spheroids: expression and co-expression with stem cell markers

Journal Articles

The serological markers TIMP-1, PAI-1, MASP-2 and CRP are independent predictors of colorectal cancer-specific death.

Anne F. Lomholt, Hans J. Nielsen, Nils Brünner, Ib J. Christensen

Cancer Res (2006) 66 (8_Supplement): 1346.

Published: 15 April 2006

View article titled, The serological markers TIMP-1, PAI-1, MASP-2 and CRP are independent predictors of colorectal cancer-specific death.

Journal Articles

Malignant transformation of wild type but not plasminogen activator inhibitor-1 gene deficient fibroblasts decreases cellular sensitivity to chemotherapy mediated apoptosis

Ulrik A. Lademann, Maria U. Romer, Nils Brünner, Peter B. Jensen, Kenneth F. Hofland, I. B. J. Christensen

Cancer Res (2005) 65 (9_Supplement): 195.

Published: 01 May 2005

View article titled, Malignant transformation of wild type but not plasminogen activator inhibitor-1 gene deficient fibroblasts decreases cellular sensitivity to chemotherapy mediated apoptosis

Journal Articles

Urokinase-Type Plasminogen Activator System in Breast Cancer: Association with Tamoxifen Therapy in Recurrent Disease

Marion E. Meijer-van Gelder, Maxime P. Look, Harry A. Peters, Manfred Schmitt, Nils Brünner, Nadia Harbeck, Jan G. M. Klijn, John A. Foekens

Cancer Res (2004) 64 (13): 4563–4568.

https://doi.org/10.1158/0008-5472.CAN-03-3848

Published: 01 July 2004

View article titled, Urokinase-Type Plasminogen Activator System in Breast Cancer: <subtitle>Association with Tamoxifen Therapy in Recurrent Disease</subtitle>

Journal Articles

Association of Interferon Regulatory Factor-1, Nucleophosmin, Nuclear Factor-κB, and Cyclic AMP Response Element Binding with Acquired Resistance to Faslodex (ICI 182,780)

Zhiping Gu, Richard Y. Lee, Todd C. Skaar, Kerrie B. Bouker, James N. Welch, Jianping Lu, Aiyi Liu, Yuelin Zhu, Natalie Davis, Fabio Leonessa, Nils Brünner, Yue Wang, Robert Clarke

Cancer Res (2002) 62 (12): 3428–3437.

Published: 01 June 2002

View article titled, Association of Interferon Regulatory Factor-1, Nucleophosmin, Nuclear Factor-κB, and Cyclic AMP Response Element Binding with Acquired Resistance to Faslodex (ICI 182,780)

Journal Articles

Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model

Thomas Leth Frandsen, Claus Holst-Hansen, Boye Schnack Nielsen, Ib Jarle Christensen, Jens R. Nyengaard, Peter Carmeliet, Nils Brünner

Cancer Res (2001) 61 (2): 532–537.

Published: 01 January 2001

View article titled, Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined <em>uPA</em> Gene-Disrupted and Immunodeficient Xenograft Model

Journal Articles

The Complex between Urokinase and Its Type-1 Inhibitor in Primary Breast Cancer: Relation to Survival

Anders N. Pedersen, Ib J. Christensen, Ross W. Stephens, Per Briand, Henning T. Mouridsen, Keld Danø, Nils Brünner;

Cancer Res (2000) 60 (24): 6927–6934.

Published: 01 December 2000

View article titled, The Complex between Urokinase and Its Type-1 Inhibitor in Primary Breast Cancer: Relation to Survival

Journal Articles

The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients

John A. Foekens, Harry A. Peters, Maxime P. Look, Henk Portengen, Manfred Schmitt, Michael D. Kramer, Nils Brünner, Fritz Jänicke, Marion E. Meijer-van Gelder, Sonja C. Henzen-Logmans, Wim L. J. van Putten, Jan G. M. Klijn

Cancer Res (2000) 60 (3): 636–643.

Published: 01 February 2000

View article titled, The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients

NARROW

Abstract 1157: MicroRNA-625-3p is associated with response to first-line oxaliplatin-based treatment of metastatic colorectal cancer.

Abstract 1912: An explorative analysis of ERCC1/ERCC4 copy number alterations in a chemonaive stage III colorectal cancer patient cohort.

Abstract LB-476: A universal method for elimination of haemolyzed plasma samples that improves miRNA signature performance for early detection of colorectal cancer

Abstract 5563: Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

Abstract 2816: Discovery of a miRNA-based RT-qPCR signature able to detect early stage colorectal cancer in blood plasma

Abstract 1214: TIMP-1 and the TIMP-1 interacting cell surface protein CD63 in cultured astrocytoma derived spheroids: expression and co-expression with stem cell markers

The serological markers TIMP-1, PAI-1, MASP-2 and CRP are independent predictors of colorectal cancer-specific death.

Malignant transformation of wild type but not plasminogen activator inhibitor-1 gene deficient fibroblasts decreases cellular sensitivity to chemotherapy mediated apoptosis

Urokinase-Type Plasminogen Activator System in Breast Cancer: Association with Tamoxifen Therapy in Recurrent Disease

Association of Interferon Regulatory Factor-1, Nucleophosmin, Nuclear Factor-κB, and Cyclic AMP Response Element Binding with Acquired Resistance to Faslodex (ICI 182,780)

Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model

The Complex between Urokinase and Its Type-1 Inhibitor in Primary Breast Cancer: Relation to Survival

The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only